SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 136 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $551,000 | +26.1% | 36,720 | +2.2% | 0.00% | – |
| Q1 2016 | $437,000 | -9.0% | 35,946 | +19.2% | 0.00% | -100.0% |
| Q4 2015 | $480,000 | +26.3% | 30,163 | +21.5% | 0.00% | 0.0% |
| Q3 2015 | $380,000 | -49.3% | 24,816 | -19.5% | 0.00% | 0.0% |
| Q2 2015 | $750,000 | +34.9% | 30,829 | +29.1% | 0.00% | 0.0% |
| Q1 2015 | $556,000 | +54.0% | 23,879 | +66.2% | 0.00% | – |
| Q4 2014 | $361,000 | -7.4% | 14,365 | +14.4% | 0.00% | – |
| Q3 2014 | $390,000 | +18.9% | 12,556 | -1.3% | 0.00% | – |
| Q2 2014 | $328,000 | +15.1% | 12,718 | +4.5% | 0.00% | – |
| Q1 2014 | $285,000 | +5.2% | 12,173 | +13.9% | 0.00% | – |
| Q4 2013 | $271,000 | +39.7% | 10,683 | +12.5% | 0.00% | – |
| Q3 2013 | $194,000 | – | 9,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|